Top 20 of Lymphoma

Article title # Publications/# Citations

Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

1983: TMosmann;

2577

High-resolution profiling of histone methylations in the human genome.

2007: ABarski; IChepelev; SCuddapah; KCui; TYRoh; DESchones; ZWang; GWei; KZhao;

1688

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

1980: PABunn; RCGallo; AFGazdar; JDMinna; BJPoiesz; FWRuscetti;

835

ras oncogenes in human cancer: a review.

1989: JLBos;

741

An inhibitor of Bcl-2 family proteins induces regression of solid tumours.

2005: RCArmstrong; DJAugeri; BABelli; MBruncko; TLDeckwerth; JDinges; SWElmore; SWFesik; ... PJHajduk; MKJoseph; SKitada; SJKorsmeyer; ARKunzer; ALetai; CLi; MJMitten; DGNettesheim; SNg; PMNimmer; JMO'Connor; AOleksijew; TOltersdorf; AMPetros; JCReed; SHRosenberg; WShen; ARShoemaker; SKTahir; CBThompson; KJTomaselli; BWang; MDWendt; HZhang;

660

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.

1990: DHockenbery; SJKorsmeyer; CMilliman; GNuñez; RDSchreiber;

417

Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.

1981: SMAstrin; WSHayward; BGNeel;

404

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.

1985 Dec 12-18: JMAdams; WSAlexander; RLBrinster; LMCorcoran; SCory; AWHarris; RDPalmiter; CAPinkert;

379

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

1994: PMBanks; JKChan; MLCleary; CDe Wolf-Peeters; GDelsol; BFalini; KCGatter; NLHarris; ESJaffe; HStein;

374

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma.

1997: CAdida; DCAltieri; GAmbrosini;

359

The global health burden of infection-associated cancers in the year 2002.

2006: DMParkin;

359

Epstein-Barr virus: 40 years on.

2004: ABRickinson; LSYoung;

341

Restoration of p53 function leads to tumour regression in vivo.

2007: JGrimm; TJacks; DGKirsch; LLintault; MEMcLaughlin; JNewman; EEReczek; DATuveson; AVentura; RWeissleder;

340

A new class of murine leukemia virus associated with development of spontaneous lymphomas.

1977: JWHartley; LJOld; WPRowe; NKWolford;

331

Reverse engineering of regulatory networks in human B cells.

2005: KBasso; ACalifano; RDalla-Favera; UKlein; AAMargolin; GStolovitzky;

321

Atm-deficient mice: a paradigm of ataxia telangiectasia.

1996: CBarlow; FCollins; JNCrawley; MEckhaus; SHirotsune; MLiyanage; RPaylor; TRied; ... YShiloh; DTagle; AWynshaw-Boris;

302

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1986 Feb 20-26: KKärre; RKiessling; HGLjunggren; GPiontek;

297

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.

2008: DPCalado; JMHenderson; JLKutok; HCPatterson; KRajewsky; LSrinivasan; JWang; CXiao; BZhang;

289

FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.

2007: DRCarrasco; DHCastrillon; LChin; GChu; RADePinho; ZDing; DGGilliland; JWHorner; ... HJi; SJiang; RKollipara; LMiao; JHPaik; ZTothova; WHWong; YXiao;

269

Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.

2001: RTBronson; DCrowley; DGreenbaum; TJacks; LJohnson; KMercer; DATuveson;

268